Posts by Admin BioAlps
Asceneuron | Appoints new Board Member
Underscores company’s ambition to deliver on the unmet needs of patients living with neurodegenerative diseases
Read MoreDrug Discovery World | Switzerland as a global biotech hub
Why Switzerland continues to punch above its weight as global biotech hub | Drug Discovery World To understand Switzerland’s continued success in the biotech sector and gain personal insights, Lu Rahman spoke to Michael Altorfer (CEO of the Swiss Biotech Association), Jan Lucht (Head of Biotechnology, scienceindustries), Claude Joris (Secretary General, BioAlps), and Carole Delauney (Business Development Director at swissfillon). With a population…
Read MoreSIB | Discover the SIB Remarkable Outputs 2020
Discover 10 Remarkable Outputs of 2020, brought to you by scientists from the SIB Swiss Institute of Bioinformatics, across Switzerland.
Read MoreAsceneuron SA | Awarded by the Alzheimer’s Drug Discovery Foundation
Asceneuron Receives USD 2.2 Million Award from the Alzheimer’s Drug Discovery Foundation. Award will fund first in human clinical trials of next generation O-GlcNAcase inhibitor, ASN51, to start Q2 2021
Read MoreADR-AC | A new testing service against the new Coronavirus 2019
ADR-AC GmbH, Bern launches a laboratory analysis test service for memory T cells against the novel 2019 Coronavirus
Read MoreSICHH | “Connect People with Science” platform
A new scientific communication platform A new scientific communication platform entitled “Connect People with Science” is being launched. Its primary objective will be to improve and simplify information about Covid-19 for the general public. Supported by the WHO, this platform is the result of a partnership between the Swiss Integrative Center for Human Health…
Read MorePlair SA – MBV | Signature of a collaboration agreement
Signature of a collaboration agreement to develop next-generation solutions for rapid microbiological detection Plair SA, the Swiss creator, manufacturer, and provider of instruments for real-time bioaerosol monitoring, and MBV AG, the Swiss global leader in viable air sampling, jointly announce on 2 November 2020 the start of a strategic partnership to bring to the market…
Read MoreCOVID-19 Testimonial Series | Laboratory of Biological Network Characterization (LBNC)
Next generation microfluidic devices for applications in molecular diagnostics The following article is part of BioAlps’ testimonial series and was written by Prof. Sebastian Maerkl, Associate Professor, Laboratory of Biological Network Characterization (LBNC). Our series aims to provide a platform for the different life sciences actors from western Switzerland, who are active in finding…
Read MoreCOVID-19 Testimonial Series | EPFL’s Laboratory of Microbiology and Microtechnology
Cutting-edge microfluidics to study the behaviour of bacterial pathogens under fluctuating environments The following article is part of BioAlps’ testimonial series and was written by Dr. Vivek Thacker, Scientist at EPFL School of Life Sciences Laboratory of Microbiology and Microtechnology. Our series aims to provide a platform for the different life sciences actors from…
Read MoreCSL Behring | Opening of a new manufacturing facility in Bern (Switzerland)
To meet the high demands for immunoglobulin products, CSL Behring is expanding its manufacturing capacities in Bern The new state-of-the-art manufacturing facility in Bern (Wankdorf) is home to the production of immunoglobulins (Ig), which allow people worldwide with serious and rare diseases to live life to the fullest. A huge investment project in Bern…
Read More